HEADER HYDROLASE/HYDROLASE INHIBITOR 15-NOV-12 4HZW TITLE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH TITLE 2 LANINAMIVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAMINIDASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 83-469; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 489926; SOURCE 4 STRAIN: 2006(H2N3); SOURCE 5 GENE: NA; SOURCE 6 EXPRESSION_SYSTEM_CELL: HI5; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS NEURAMINIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.LI,J.QI,C.J.VAVRICKA,G.F.GAO REVDAT 4 13-NOV-24 4HZW 1 REMARK REVDAT 3 08-NOV-23 4HZW 1 HETSYN REVDAT 2 29-JUL-20 4HZW 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 LINK SITE ATOM REVDAT 1 06-NOV-13 4HZW 0 JRNL AUTH Q.LI,J.QI,Y.WU,H.KIYOTA,K.TANAKA,Y.SUHARA,H.OHRUI,Y.SUZUKI, JRNL AUTH 2 C.J.VAVRICKA,G.F.GAO JRNL TITL FUNCTIONAL AND STRUCTURAL ANALYSIS OF INFLUENZA VIRUS JRNL TITL 2 NEURAMINIDASE N3 OFFERS FURTHER INSIGHT INTO THE MECHANISMS JRNL TITL 3 OF OSELTAMIVIR RESISTANCE. JRNL REF J.VIROL. V. 87 10016 2013 JRNL REFN ISSN 0022-538X JRNL PMID 23824808 JRNL DOI 10.1128/JVI.01129-13 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.5_2) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.080 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 39081 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.138 REMARK 3 R VALUE (WORKING SET) : 0.137 REMARK 3 FREE R VALUE : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1961 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.5194 - 4.0975 0.99 2821 151 0.1362 0.1363 REMARK 3 2 4.0975 - 3.2532 1.00 2797 139 0.1223 0.1292 REMARK 3 3 3.2532 - 2.8422 0.99 2739 125 0.1383 0.1523 REMARK 3 4 2.8422 - 2.5824 0.99 2723 152 0.1481 0.1585 REMARK 3 5 2.5824 - 2.3974 0.99 2746 145 0.1423 0.1718 REMARK 3 6 2.3974 - 2.2561 0.97 2681 144 0.1420 0.1698 REMARK 3 7 2.2561 - 2.1431 0.97 2693 119 0.1324 0.1743 REMARK 3 8 2.1431 - 2.0498 0.97 2644 144 0.1289 0.1424 REMARK 3 9 2.0498 - 1.9709 0.96 2674 116 0.1281 0.1578 REMARK 3 10 1.9709 - 1.9029 0.93 2530 163 0.1436 0.1992 REMARK 3 11 1.9029 - 1.8434 0.92 2495 159 0.1338 0.1723 REMARK 3 12 1.8434 - 1.7907 0.94 2565 136 0.1309 0.1685 REMARK 3 13 1.7907 - 1.7436 0.94 2556 137 0.1261 0.1672 REMARK 3 14 1.7436 - 1.7011 0.89 2456 131 0.1346 0.1771 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 32.30 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 13.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.70820 REMARK 3 B22 (A**2) : -1.70820 REMARK 3 B33 (A**2) : 3.41630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3236 REMARK 3 ANGLE : 1.140 4390 REMARK 3 CHIRALITY : 0.122 477 REMARK 3 PLANARITY : 0.006 561 REMARK 3 DIHEDRAL : 23.066 1210 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -0.2372 -28.0443 26.8902 REMARK 3 T TENSOR REMARK 3 T11: 0.0323 T22: 0.0231 REMARK 3 T33: 0.0251 T12: -0.0003 REMARK 3 T13: -0.0020 T23: 0.0011 REMARK 3 L TENSOR REMARK 3 L11: 0.2015 L22: 0.2248 REMARK 3 L33: 0.1062 L12: -0.0181 REMARK 3 L13: 0.0075 L23: 0.0306 REMARK 3 S TENSOR REMARK 3 S11: -0.0022 S12: 0.0106 S13: -0.0304 REMARK 3 S21: -0.0103 S22: 0.0104 S23: 0.0012 REMARK 3 S31: 0.0193 S32: 0.0009 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HZW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39081 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2BAT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20MM TRIS, PH 8.0, 50MM NACL, 0.1M BIS REMARK 280 -TRIS PROPANE (PH 9.0), 10% V/V JEFFAMINE ED-2001 (PH 7.0), REMARK 280 VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 52.98850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.98850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 33.39950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 52.98850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.98850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.39950 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 52.98850 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 52.98850 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 33.39950 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 52.98850 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 52.98850 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 33.39950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CA CA A 508 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 647 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 696 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 921 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 100 -85.56 -114.13 REMARK 500 ASP A 125 -159.94 -108.75 REMARK 500 ASP A 200 41.23 -161.41 REMARK 500 ASP A 221 73.81 -150.59 REMARK 500 THR A 225 -153.97 -139.57 REMARK 500 ALA A 247 39.46 -140.85 REMARK 500 LYS A 272A -58.13 -120.42 REMARK 500 ILE A 284 -67.24 66.66 REMARK 500 CYS A 291 -165.37 -123.56 REMARK 500 TRP A 295 -76.01 -114.17 REMARK 500 ASN A 306 -167.47 -113.60 REMARK 500 GLU A 308 -31.20 -131.52 REMARK 500 SER A 319 123.14 -38.84 REMARK 500 SER A 332 -149.22 -115.64 REMARK 500 PRO A 347 -99.43 -88.14 REMARK 500 SER A 404 -131.07 -117.00 REMARK 500 ALA A 414 -150.37 -97.52 REMARK 500 LYS A 415 -76.76 -63.36 REMARK 500 ASN A 433 -2.27 77.87 REMARK 500 ASP A 450 39.73 -85.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 507 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 293 O REMARK 620 2 GLY A 297 O 82.6 REMARK 620 3 ASP A 324 OD2 89.9 88.6 REMARK 620 4 GLY A 345 O 100.5 85.1 167.1 REMARK 620 5 PRO A 347 O 93.8 169.0 101.8 85.4 REMARK 620 6 HOH A 602 O 176.4 93.8 90.1 79.1 89.7 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TI3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDLL ASE COMPLEXED REMARK 900 WITH LANINAMIVIR REMARK 900 RELATED ID: 3TIA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED REMARK 900 WITH LANINAMIVIR REMARK 900 RELATED ID: 3TI8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED REMARK 900 WITH LANINAMIVIR REMARK 900 RELATED ID: 4HZV RELATED DB: PDB REMARK 900 RELATED ID: 4HZX RELATED DB: PDB REMARK 900 RELATED ID: 4HZY RELATED DB: PDB REMARK 900 RELATED ID: 4HZZ RELATED DB: PDB REMARK 900 RELATED ID: 4I00 RELATED DB: PDB DBREF 4HZW A 83 469 UNP A9YN63 A9YN63_9INFA 83 469 SEQADV 4HZW PHE A 82 UNP A9YN63 EXPRESSION TAG SEQRES 1 A 388 PHE ARG PRO PHE LYS SER PRO LEU PRO LEU CYS PRO PHE SEQRES 2 A 388 ARG GLY PHE PHE PRO PHE HIS LYS ASP ASN ALA ILE ARG SEQRES 3 A 388 LEU GLY GLU ASN LYS ASP VAL ILE VAL THR ARG GLU PRO SEQRES 4 A 388 TYR VAL SER CYS ASP ASN ASP ASN CYS TRP SER PHE ALA SEQRES 5 A 388 LEU ALA GLN GLY ALA LEU LEU GLY THR LYS HIS SER ASN SEQRES 6 A 388 GLY THR ILE LYS ASP ARG THR PRO TYR ARG SER LEU ILE SEQRES 7 A 388 ARG PHE PRO ILE GLY THR ALA PRO VAL LEU GLY ASN TYR SEQRES 8 A 388 LYS GLU ILE CYS ILE ALA TRP SER SER SER SER CYS PHE SEQRES 9 A 388 ASP GLY LYS GLU TRP MET HIS VAL CYS MET THR GLY ASN SEQRES 10 A 388 ASP ASN ASP ALA SER ALA GLN ILE ILE TYR GLY GLY ARG SEQRES 11 A 388 MET THR ASP SER ILE LYS SER TRP ARG LYS ASP ILE LEU SEQRES 12 A 388 ARG THR GLN GLU SER GLU CYS GLN CYS ILE ASP GLY THR SEQRES 13 A 388 CYS VAL VAL ALA VAL THR ASP GLY PRO ALA ALA ASN SER SEQRES 14 A 388 ALA ASP TYR ARG VAL TYR TRP ILE ARG GLU GLY LYS ILE SEQRES 15 A 388 ILE LYS TYR GLU ASN VAL PRO LYS THR LYS ILE GLN HIS SEQRES 16 A 388 LEU GLU GLU CYS SER CYS TYR VAL ASP ILE ASP VAL TYR SEQRES 17 A 388 CYS ILE CYS ARG ASP ASN TRP LYS GLY SER ASN ARG PRO SEQRES 18 A 388 TRP MET ARG ILE ASN ASN GLU THR ILE LEU GLU THR GLY SEQRES 19 A 388 TYR VAL CYS SER LYS PHE HIS SER ASP THR PRO ARG PRO SEQRES 20 A 388 ALA ASP PRO SER THR MET SER CYS ASP SER PRO SER ASN SEQRES 21 A 388 VAL ASN GLY GLY PRO GLY VAL LYS GLY PHE GLY PHE LYS SEQRES 22 A 388 ALA GLY ASP ASP VAL TRP LEU GLY ARG THR VAL SER THR SEQRES 23 A 388 SER GLY ARG SER GLY PHE GLU ILE ILE LYS VAL THR GLU SEQRES 24 A 388 GLY TRP ILE ASN SER PRO ASN HIS VAL LYS SER ILE THR SEQRES 25 A 388 GLN THR LEU VAL SER ASN ASN ASP TRP SER GLY TYR SER SEQRES 26 A 388 GLY SER PHE ILE VAL LYS ALA LYS ASP CYS PHE GLN PRO SEQRES 27 A 388 CYS PHE TYR VAL GLU LEU ILE ARG GLY ARG PRO ASN LYS SEQRES 28 A 388 ASN ASP ASP VAL SER TRP THR SER ASN SER ILE VAL THR SEQRES 29 A 388 PHE CYS GLY LEU ASP ASN GLU PRO GLY SER GLY ASN TRP SEQRES 30 A 388 PRO ASP GLY SER ASN ILE GLY PHE MET PRO LYS MODRES 4HZW ASN A 146 ASN GLYCOSYLATION SITE MODRES 4HZW ASN A 307 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET FUC B 3 10 HET NAG C 1 14 HET NAG C 2 14 HET FUC C 3 10 HET CA A 507 1 HET CA A 508 1 HET LNV A 509 24 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM LNV 5-ACETAMIDO-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5- HETNAM 2 LNV TRIDEOXY-7-O-METHYL-D-GLYCERO-D-GALACTO-NON-2-ENONIC HETNAM 3 LNV ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN LNV 5-(ACETYLAMINO)-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5- HETSYN 2 LNV TRIDEOXY-7-O-METHYL-D-GLYCERO-D-GALACTO-NON-2-ENONIC HETSYN 3 LNV ACID; LANINAMIVIR FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 FUC 2(C6 H12 O5) FORMUL 4 CA 2(CA 2+) FORMUL 6 LNV C13 H22 N4 O7 FORMUL 7 HOH *445(H2 O) HELIX 1 1 ASN A 104 GLY A 109 1 6 HELIX 2 2 THR A 142 ASN A 146 5 5 HELIX 3 3 ASN A 463 MET A 467 5 5 SHEET 1 A 4 GLY A 96 LYS A 102 0 SHEET 2 A 4 THR A 439 LEU A 449 -1 O THR A 445 N PHE A 100 SHEET 3 A 4 PHE A 418 GLY A 429 -1 N PRO A 420 O GLY A 448 SHEET 4 A 4 SER A 407 LYS A 413 -1 N VAL A 412 O GLN A 419 SHEET 1 B 4 ILE A 115 CYS A 124 0 SHEET 2 B 4 CYS A 129 LEU A 139 -1 O PHE A 132 N TYR A 121 SHEET 3 B 4 SER A 157 PRO A 162 -1 O SER A 157 N ALA A 135 SHEET 4 B 4 LYS A 172 ILE A 176 -1 O ILE A 174 N LEU A 158 SHEET 1 C 4 SER A 179 PHE A 184 0 SHEET 2 C 4 TRP A 189 THR A 195 -1 O MET A 190 N CYS A 183 SHEET 3 C 4 SER A 202 TYR A 207 -1 O GLN A 204 N CYS A 193 SHEET 4 C 4 ARG A 210 LYS A 216 -1 O ASP A 213 N ILE A 205 SHEET 1 D 4 GLN A 231 ILE A 233 0 SHEET 2 D 4 THR A 236 ASP A 243 -1 O VAL A 238 N GLN A 231 SHEET 3 D 4 ASP A 251 ARG A 258 -1 O ILE A 257 N CYS A 237 SHEET 4 D 4 LYS A 261 ASN A 267 -1 O ILE A 263 N TRP A 256 SHEET 1 E 4 GLU A 276 VAL A 282 0 SHEET 2 E 4 VAL A 287 ARG A 292 -1 O TYR A 288 N TYR A 281 SHEET 3 E 4 PRO A 301 ILE A 305 -1 O ILE A 305 N VAL A 287 SHEET 4 E 4 ILE A 311 TYR A 316 -1 O GLY A 315 N TRP A 302 SHEET 1 F 4 GLY A 353 ALA A 356 0 SHEET 2 F 4 ASP A 359 ARG A 364 -1 O TRP A 361 N PHE A 354 SHEET 3 F 4 SER A 372 THR A 380 -1 O VAL A 379 N VAL A 360 SHEET 4 F 4 VAL A 390 TRP A 403 -1 O ASP A 402 N GLY A 373 SSBOND 1 CYS A 92 CYS A 417 1555 1555 2.04 SSBOND 2 CYS A 124 CYS A 129 1555 1555 2.05 SSBOND 3 CYS A 175 CYS A 193 1555 1555 2.02 SSBOND 4 CYS A 183 CYS A 230 1555 1555 2.03 SSBOND 5 CYS A 232 CYS A 237 1555 1555 2.05 SSBOND 6 CYS A 278 CYS A 291 1555 1555 2.06 SSBOND 7 CYS A 280 CYS A 289 1555 1555 2.04 SSBOND 8 CYS A 318 CYS A 337 1555 1555 2.06 SSBOND 9 CYS A 421 CYS A 447 1555 1555 2.07 LINK ND2 ASN A 146 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 307 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O6 NAG B 1 C1 FUC B 3 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O6 NAG C 1 C1 FUC C 3 1555 1555 1.44 LINK O ASP A 293 CA CA A 507 1555 1555 2.35 LINK O GLY A 297 CA CA A 507 1555 1555 2.47 LINK OD2 ASP A 324 CA CA A 507 1555 1555 2.38 LINK O GLY A 345 CA CA A 507 1555 1555 2.40 LINK O PRO A 347 CA CA A 507 1555 1555 2.34 LINK CA CA A 507 O HOH A 602 1555 1555 2.45 LINK CA CA A 508 O HOH A 835 1555 1555 3.00 CISPEP 1 THR A 325 PRO A 326 0 5.21 CISPEP 2 ASP A 330 PRO A 331 0 -8.99 CISPEP 3 GLY A 346 PRO A 347 0 -1.55 CISPEP 4 ARG A 430 PRO A 431 0 6.21 CRYST1 105.977 105.977 66.799 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009436 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009436 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014970 0.00000